We are a GI-focused CRO with proven in-depth GI-specific knowledge throughout the entire organization and finely tuned operational workflows developed by our industry-leading KOLs.

Watch our expert panel provide an overview of nonalcoholic steatohepatitis (NASH) including a review of the drug development landscape, imaging as a non-invasive measure in NASH Clinical Trials, and the role of histopathology and machine learning in NASH Clinical Trials. Featured presentations include:

• Overview of the Current and Evolving Drug Development Landscape in 2022
• The Role of Imaging as a Non-Invasive Measurement in NASH Clinical Trials
• The Role of Histopathology and Machine Learning in NASH Clinical Trials